Type II Pneumocytes in Pulmonary Tumors. Implications for Histogenesis
Overview
Authors
Affiliations
Bronchioloalveolar carcinomas (n = 45), intravascular bronchiolo-alveolar tumors (n = 8), and sclerosing hemangiomas of the lung (n = 2) were stained for surfactant apoprotein by the immunoperoxidase method. Of the bronchiolo-alveolar carcinomas, 12 were found to be carcinomas of type II pneumocytes and the remaining 33 tumors were designated as nontype II pneumocytic bronchiolo-alveolar carcinomas. Twenty-five of these tumors displayed trapped benign type II pneumocytes within the tumor masses. In the case of intravascular bronchioloalveolar tumors, none of the tumors demonstrated staining of tumor cells for surfactant apoprotein. In the two cases of sclerosing hemangiomas, the type II pneumocytes were exuberant and numerous, and in one case contained intranuclear inclusions of surfactant apoprotein. This article discusses the implication of the presence of benign type II pneumocytes in pulmonary tumors.
Alveolar adenoma of the lung: further characterization of this uncommon tumour.
Oliveira P, Nunes J, Clode A, da Costa J, Almeida M Virchows Arch. 1996; 429(2-3):101-8.
PMID: 8917711 DOI: 10.1007/BF00192432.
HAMMOND W, Benfield J, TEPLITZ R, Dijkman J Am J Pathol. 1993; 142(4):1251-64.
PMID: 8386445 PMC: 1886860.
Rehm S, Devor D J Cancer Res Clin Oncol. 1993; 120(1-2):41-50.
PMID: 8270607 DOI: 10.1007/BF01200723.
Ward J, Singh G, Katyal S, Anderson L, Kovatch R Am J Pathol. 1985; 118(3):493-9.
PMID: 3883798 PMC: 1887948.
Pulmonary adenocarcinoma: review of 106 cases and proposed new classification.
Edwards C J Clin Pathol. 1987; 40(2):125-35.
PMID: 3818979 PMC: 1140854. DOI: 10.1136/jcp.40.2.125.